Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): Considerations for routine screening and management

Nephrology Dialysis Transplantation

Volumn 29, Issue 2, 2014, Pages 247-254

  Luciano, Randy L ^a   Dahl, Neera K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADPKD; extra renal; screening

Indexed keywords

ANGIOPEPTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OCTREOTIDE; PLACEBO; POLYCYSTIN 1; POLYCYSTIN 2;

ABDOMINAL WALL HERNIA; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN CYST; BRONCHIECTASIS; CHRONIC KIDNEY DISEASE; COMORBIDITY; DISEASE SEVERITY; DIVERTICULOSIS; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFERTILITY; INTRACRANIAL ANEURYSM; KIDNEY CYST; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER POLYCYSTIC DISEASE; MORBIDITY; MORTALITY; MUTATIONAL ANALYSIS; PAIN; PANCREAS CYST; PERICARDIAL EFFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCREENING TEST; SUBDURAL HEMATOMA;

ADPKD; EXTRA-RENAL; SCREENING;

CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; DIGESTIVE SYSTEM DISEASES; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MASS SCREENING; MORBIDITY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; SURVIVAL RATE; WORLD HEALTH;

EID: 84896705717     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft437     Document Type: Review

References (83)

1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
2. Hughes J, Ward CJ, Peral B et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995; 10: 151-160
3. Mochizuki T, Wu G, Hayashi T et al. PKD2, A gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342
4. Gonzalez-Perrett S, Kim K, Ibarra C et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 2001; 98: 1182-1187
5. Qian F, Germino FJ, Cai Y et al. PKD1 Interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997; 16: 179-183
6. Drummond IA. Polycystins, focal adhesions and extracellular matrix interactions. Biochim Biophys Acta 2011; 1812: 1322-1326
7. Bae KT, Zhu F, Chapman AB et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of polycystic kidney disease cohort. Clin J Am Soc Nephrol 2006; 1: 64-69
8. Chapman AB. Cystic disease in women: Clinical characteristics and medical management. Adv Ren Replace Ther 2003; 10: 24-30
9. Gabow PA, Johnson AM, Kaehny WD et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033-1037
10. Torres VE, Chapman AB, Perrone RD et al. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int 2012; 81: 577-585
11. Drenth JP, Chrispijn M, Nagorney DM et al. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-2230
12. Jouret F, Lhommel R, Devuyst O et al. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: Attributes and limitations of the current modalities. Nephrol Dial Transplant 2012; 27: 3746-3751
13. Kanaan N, Goffin E, Pirson Y et al. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2010; 55: 916-922
14. Chandok N. Polycystic liver disease: A clinical review. Ann Hepatol 2012; 11: 819-826
15. Kirchner GI, Rifai K, Cantz T et al. Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl 2006; 12: 1268-1277
16. Jouret F, Lhommel R, Beguin C et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1644-1650
17. Hogan MC, Masyuk TV, Page LJ et al. Randomized clinical trial of longacting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010; 21: 1052-1061
18. Hogan MC, Masyuk TV, Page L et al. Somatostatin analog therapy for severe polycystic liver disease: Results after 2 years. Nephrol Dial Transplant 2012; 27: 3532-3539
19. Chrispijn M, Nevens F, Gevers TJ et al. The long-Term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther 2012; 35: 266-274
20. Qian Q, Du H, King BF et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol 2008; 19: 631-638
21. Iglesias CG, Torres VE, Offord KP et al. Epidemiology of adult polycystic kidney disease, Olmsted county, Minnesota: 1935-1980. Am J Kidney Dis 1983; 2: 630-639
22. Torra R, Nicolau C, Badenas C et al. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 1997; 47: 19-22
23. Malka D, Hammel P, Vilgrain V et al. Chronic obstructive pancreatitis due to a pancreatic cyst in a patient with autosomal dominant polycystic kidney disease. Gut 1998; 42: 131-134
24. Schievink WI, Huston J, 3rd, Torres VE et al. Intracranial cysts in autosomal dominant polycystic kidney disease. J Neurosurg 1995; 83: 1004-1007
25. Wijdicks EF, Torres VE, Schievink WI. Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000; 35: 40-43
26. Leung GK, Fan YW. Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD). J Clin Neurosci 2005; 12: 817-819
27. Krauer FU, Kollias S, Bleisch J et al. Growth of arachnoid cysts in patient with autosomal dominant polycystic kidney disease: Serial imaging and clinical relevance. Clin Kidney J 2012; 5: 405-411
28. Coche E, Persu A, Cosnard G et al. Multiple thoracic paraspinal meningeal cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003; 41: E8
29. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002; 13: 269-276
30. Belz MM, Hughes RL, Kaehny WD et al. Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2001; 38: 770-776
31. Ring T, Spiegelhalter D. Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. Kidney Int 2007; 72: 1400-1402
32. Gibbs GF, Huston J, III, Qian Q et al. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 2004; 65: 1621-1627
33. Irazabal MV, Huston J, III, Kubly V et al. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1274-1285
34. Belz MM, Fick-Brosnahan GM, Hughes RL et al. Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 2003; 63: 1824-1830
35. Schrier RW, Belz MM, Johnson AM et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: A prospective ten-year follow-up. J Am Soc Nephrol 2004; 15: 1023-1028
36. Butler WE, Barker FG, II, Crowell RM. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: A decision analysis. Neurosurgery 1996; 38: 506-515; discussion 515-6
37. Xu HW, Yu SQ, Mei CL et al. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011; 42: 204-206
38. Rossetti S, Chauveau D, Kubly V et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003; 361: 2196-2201
39. Chapman JR, Hilson AJ. Polycystic kidneys and abdominal aortic aneurysms. Lancet 1980; 1: 646-647
40. Torra R, Nicolau C, Badenas C et al. Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1996; 7: 2483-2486
41. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: E463-e654
42. Florijn KW, Noteboom WM, Van Saase JL et al. A century of mortality in five large families with polycystic kidney disease. Am J Kidney Dis 1995; 25: 370-374
43. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. J Am Soc Nephrol 2001; 12: 194-200
44. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-228
45. Sedman A, Bell P, Manco-Johnson M et al. Autosomal dominant polycystic kidney disease in childhood: A longitudinal study. Kidney Int 1987; 31: 1000-1005
46. Gabow PA, Chapman AB, Johnson AM et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1990; 38: 1177-1180
47. Chapman AB, Guay-Woodford LM, Grantham JJ et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 2003; 64: 1035-1045
48. Almeida EA, Oliveira EI, Lopes JA et al. Tissue Doppler imaging in the evaluation of left ventricular function in young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2006; 47: 587-592
49. de Almeida EA, de Oliveira EI, Lopes JA et al. Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease. Rev Port Cardiol 2007; 26: 235-243
50. Schrier RW. Renal volume, renin-Angiotensin-Aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2009; 20: 1888-1893
51. Lumiaho A, Pihlajamaki J, Hartikainen J et al. Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am J Kidney Dis 2003; 41: 1219-1224
52. Chapman AB, Johnson AM, Rainguet S et al. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1292-1297
53. Perrone RD, Abebe KZ, Schrier RW et al. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2508-2515
54. Patch C, Charlton J, Roderick PJ et al. Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: A population-based study. Am J Kidney Dis 2011; 57: 856-862
55. Hossack KF, Leddy CL, Johnson AM et al. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907-912
56. Ivy DD, Shaffer EM, Johnson AM et al. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2032-2036
57. Lumiaho A, Ikaheimo R, Miettinen R et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 2001; 38: 1208-1216
58. Hughes LE. Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis. Gut 1969; 10: 336-344
59. Sharp CK, Zeligman BE, Johnson AM et al. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am J Kidney Dis 1999; 34: 863-868
60. Scheff RT, Zuckerman G, Harter H et al. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med 1980; 92(2 Pt 1): 202-204
61. Lederman ED, McCoy G, Conti DJ et al. Diverticulitis and polycystic kidney disease. Am Surg 2000; 66: 200-203
62. Pourfarziani V, Mousavi-Nayeeni SM, Ghaheri H et al. The outcome of diverticulosis in kidney recipients with polycystic kidney disease. Transplant Proc 2007; 39: 1054-1056
63. Dominguez Fernandez E, Albrecht KH, Heemann U et al. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int 1998; 11: 28-31
64. McCune TR, Nylander WA, Van Buren DH et al. Colonic screening prior to renal transplantation and its impact on post-Transplant colonic complications. Clin Transplant 1992; 6: 91-96
65. Morris-Stiff G, Coles G, Moore R et al. Abdominal wall hernia in autosomal dominant polycystic kidney disease. Br J Surg 1997; 84: 615-617
66. Van Dijk CM, Ledesma SG, Teitelbaum I. Patient characteristics associated with defects of the peritoneal cavity boundary. Perit Dial Int 2005; 25: 367-373
67. Li L, Szeto CC, Kwan BC et al. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2011; 57: 903-907
68. Driscoll JA, Bhalla S, Liapis H et al. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest 2008; 133: 1181-1188
69. Alpern MB, Dorfman RE, Gross BH et al. Seminal vesicle cysts: Association with adult polycystic kidney disease. Radiology 1991; 180: 79-80
70. Danaci M, Akpolat T, Bastemir M et al. The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1998; 13: 2825-2828
71. Torra R, Sarquella J, Calabia J et al. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2008; 3: 790-793
72. Hendry WF, Rickards D, Pryor JP et al. Seminal megavesicles with adult polycystic kidney disease. Hum Reprod 1998; 13: 1567-1569
73. Joo I, Kim SH, Cho JY. A comparison of seminal vesicle size on CT between autosomal dominant polycystic kidney disease (ADPKD) patients and normal subjects. Acta Radiol 2010; 51: 569-572
74. Orhan I, Onur R, Ergin E et al. Infertility treatment in autosomal dominant polycystic kidney disease (ADPKD)-A case report. Andrologia 2000; 32: 91-93
75. Kierszenbaum AL. Polycystins: What polycystic kidney disease tells us about sperm. Mol Reprod Dev 2004; 67: 385-388
76. Wilson PD, Guay-Woodford L. Pathophysiology and clinical management of polycystic kidney disease in women. Semin Nephrol 1999; 19: 123-132
77. Chapman AB, Johnson AM, Gabow PA. Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 5: 1178-1185
78. Bajwa ZH, Sial KA, Malik AB et al. Pain patterns in patients with polycystic kidney disease. Kidney Int 2004; 66: 1561-1569
79. Heiwe S, Bjuke M. 'An evil heritage': Interview study of pain and autosomal dominant polycystic kidney disease. Pain Manag Nurs 2009; 10: 134-141
80. Rizk D, Jurkovitz C, Veledar E et al. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Clin J Am Soc Nephrol 2009; 4: 560-566
81. de Barros BP, Nishiura JL, Heilberg IP et al. Anxiety, depression, and quality of life in patients with familial glomerulonephritis or autosomal dominant polycystic kidney disease. J Bras Nefrol 2011; 33: 120-128
82. Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: Cross sectional study. BMJ 2003; 327: 1144-1146
83. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968; 65: 281-393